Phase I Study of Indibulin in Patients With Solid Tumors

Status:
Completed

Trial end date:
2008-09-01

Target enrollment:

Participant gender:

Dose-finding and pharmacokinetic trial of orally administered Indibulin to patients with solid tumors.

Phase 1

Ziopharm